REFERENCES
1.
White DC: Anaesthesia: A privation of the senses.
An historical introduction and some definitions. In
Rosen M, Lunn JN (eds): Consciousness, Awareness, and Pain in General Anaesthesia.
London, Butterworths, 1987, p 1.
2.
Plomley F: Operations upon the eye [letter]. Lancet
1:134, 1847.
3.
Snow J: On the Inhalation of the Vapors of Ether
in Surgical Operations: Containing a Description of the Various Stages of Etherization,
and a Statement of the Result of Nearly Eighty Operations in Which Ether Has Been
Employed in St. George's and University College Hospitals. London, John Churchill,
1847. Reproduced by Lea & Febiger, Philadelphia, 1959.
4.
Snow J: On Chloroform and Other Anesthetics. London,
John Churchill, 1858.
5.
Gillespie NA: The signs of anaesthesia. Anesth
Analg 22:275, 1943.
6.
Guedel AE: Inhalational Anesthesia: A Fundamental
Guide. New York, Macmillan, 1937.
7.
Artusio JF Jr: Di-ethyl ether analgesia: A detailed
description of the first stage of ether analgesia in man. J Pharmacol Exp Ther 111:343,
1954.
8.
Tomas DW, Runciman WB: Monitoring depth of anesthesia.
Anaesth Intensive Care 16:69, 1988.
9.
Curare in anaesthesia [editorial]. Lancet 2:81,
1945.
10.
Winterbottom EH: Insufficient anaesthesia [letter].
BMJ 1:247, 1950.
11.
Woodbridge PD: Changing concepts concerning depth
of anesthesia. Anesthesiology 18:536, 1957.
12.
Prys-Roberts C: Anaesthesia: A practical or impossible
construct [editorial]? Br J Anaesth 59:1341, 1987.
13.
Eger EL II, Saidman LJ, Brandstater B: Minimum
alveolar anesthetic concentration: A standard of anesthetic potency. Anesthesiology
26:756, 1965.
14.
Kissin I: General anesthetic action: An obsolete
notion? Anesth Analg 76:215, 1993.
15.
Glass PS: Anesthetic drug interactions: An insight
into general anesthesia—its mechanism and dosing strategies. Anesthesiology
88:5–6, 1998.
16.
Bencherif B, Fuchs PN, Sheth R, et al: Pain activation
of human supraspinal opioid pathways as demonstrated by [11
C]-carfentanil
and positron emission tomography (PET). Pain 99:589–598, 2002.
17.
Fukuhara N, Ishikawa T, Kinoshita H, et al: Central
noradrenergic mediation of nitrous oxide-induced analgesia in rats. Can J Anaesth
45:1123–1129, 1998.
18.
Quock RM, Best JA, Chen DC, et al: Mediation of
nitrous oxide analgesia in mice by spinal and supraspinal kappa-opioid receptors.
Eur J Pharmacol 175:97–100, 1990.
19.
Fang F, Guo TZ, Davies MF, Maze M: Opiate receptors
in the periaqueductal gray mediate analgesic effect of nitrous oxide in rats. Eur
J Pharmacol 336:137–141, 1997.
20.
Egan TD, Muir KT, Hermann DJ, et al: The electroencephalogram
(EEG) and clinical measure of opioid potency: Defining the EEG-clinical potency
relationship ("fingerprint") with application to remifentanil. Int J Pharm Med 15:1–9,
2001.
21.
Wynands JE, Wong P, Townsend GE, et al: Narcotic
requirements for intravenous anesthesia. Anesth Analg 63:101, 1984.
22.
Sebel PS, Glass PS, Fletcher JE, et al: Reduction
of the MAC of desflurane with fentanyl. Anesthesiology 76:52–59, 1992.
23.
McEwan AI, Smith C, Dyar O, et al: Isoflurane
minimum alveolar concentration reduction by fentanyl. Anesthesiology 78:864, 1993.
24.
Vuyk J, Lim T, Engbers FHM, et al: The pharmacodynamic
interaction of propofol and alfentanil during lower abdominal surgery in women.
Anesthesiology 83:8, 1995.
25.
Smith C, McEwan AI, Jhaveri R, et al: The interaction
of fentanyl on the Cp50
of propofol for loss of consciousness and skin
incision. Anesthesiology 81:820–828, 1994.
26.
Kazama T, Ikeda K, Morita K: Reduction by fentanyl
of the Cp50
values of propofol and hemodynamic responses to various noxious
stimuli. Anesthesiology 87:213, 1997.
27.
Kazama T, Ikeda K, Morita K, et al: Propofol concentration
required for endotracheal intubation with a laryngoscope or fiberscope and its interaction
with fentanyl. Anesth Analg 86:872–879, 1998.
28.
Minto CF, Schnider TW, Short TG, et al: Response
surface model for anesthetic drug interactions. Anesthesiology 92:1603–1816,
2000.
29.
Rampil IJ, Mason P, Singh H: Anesthetic potency
(MAC) is independent of forebrain structures in the rat. Anesthesiology 78:707,
1993.
30.
Rampil IJ: Anesthetic potency is not altered after
hypothermic spinal cord transactions in rats. Anesthesiology 80:606, 1994.
31.
Antognini JF, Schwartz K: Exaggerated anesthetic
requirements in the preferentially anesthetized brain. Anesthesiology 79:1244, 1993.
32.
Fields HL, Anderson SD: Evidence that raphe-spinal
neurons mediate opiate and midbrain stimulation-produced analgesias. Pain 5:333–349,
1978.
33.
Kazama T, Ikeda K, Morita K: The pharmacodynamic
interaction between propofol and fentanyl with respect to the suppression of somatic
or hemodynamic responses to skin incision, peritoneum incision, and abdominal wall
retraction. Anesthesiology 89:894–906, 1998.
34.
Stoelting RK, Longnecker DE, Eger EI II: Minimum
alveolar concentrations in man on awakening from methoxyflurane, halothane, ether
and fluroxene anesthesia: MAC awake. Anesthesiology 33:5–9, 1970.
35.
Eger EI II: Age, minimum alveolar anesthetic concentration,
and minimum alveolar anesthetic concentration-awake. Anesth Analg 93:947–953,
2001.
36.
Roizen MF, Horrigan RW, Frazer BM: Anesthetic
doses blocking adrenergic (stress) and cardiovascular responses to incision—MAC
BAR. Anesthesiology 54:390–398, 1981.
37.
Daniel M, Weiskopf RB, Noorani M, Eger EI II:
Fentanyl augments the blockade of the sympathetic response to incision (MAC-BAR)
produced by desflurane and isoflurane: Desflurane and isoflurane MAC-BAR without
and with fentanyl. Anesthesiology 88:43–49, 1998.
38.
Hornbein TF, Eger EI II, Winter PM, et al: The
minimum alveolar concentration of nitrous oxide in man. Anesth Analg 61:553–556,
1982.
39.
Ausems ME, Hug CC Jr, Stanski DR, et al: Plasma
concentrations of alfentanil required to supplement nitrous oxide anesthesia for
general surgery. Anesthesiology 65:362, 1986.
40.
Ghouri AF, White PF: Effect of fentanyl and nitrous
oxide on the desflurane anesthetic requirement. Anesth Analg 72:377–381, 1991.
41.
Rampil IJ, Lockhart SH, Zwass MS, et al: Clinical
characteristics of desflurane in surgical patients: Minimum alveolar concentration.
Anesthesiology 74:429–433, 1991.
42.
Stuart PC, Stott SM, Millar A, et al: Cp50
of propofol with and without nitrous oxide 67%. Br J Anaesth 84:638–639, 2000.
43.
Ichinohe T, Aida H, Kaneko Y: Interaction of nitrous
oxide and propofol to reduce hypertensive response to stimulation. Can J Anaesth
47:699–704, 2000.
44.
Robertson HR: Without benefit of anesthesia:
George Wilson's amputation and Fanny Burney's mastectomy. Ann R Coll Physicians
Surg Can 22:27, 1989.
45.
Vickers MD: Detecting consciousness by clinical
means. In Rosen M, Lund NJ (eds): Consciousness,
Awareness, and Pain in General Anesthesia. London, Butterworths, 1987, p 12.
46.
Schacter DL: Implicit knowledge: New perspectives
on unconscious processes. Proc Natl Acad Sci U S A 89:11113, 1992.
47.
Bogetz MS, Katz JA: Recall of surgery for major
trauma. Anesthesiology 61:6, 1984.
48.
Lubke GH, Kerssens C, Phaf H, et al: Dependence
of explicit and implicit memory on hypnotic state in trauma patients. Anesthesiology
90:670, 1999.
49.
Sandin RH, Enlund G, Samuelsson P, et al: Awareness
during anaesthesia: A prospective case study. Lancet 355:707, 2000.
50.
Ghoneim MM: Awareness during anesthesia. Anesthesiology
92:597, 2000.
51.
Mark JB, Greenberg LM: Intraoperative awareness
and hypertensive crisis during high-dose fentanyl-diazepam-oxygen anesthesia. Anesth
Analg 62:698, 1983.
52.
Mummaneni N, Rao TLK, Montoya A: Awareness and
recall with high-dose fentanyl-oxygen anesthesia. Anesth Analg 59:948, 1980.
53.
Hilgenberg JC: Intraoperative awareness during
high dose fentanyl-oxygen anaesthesia. Anesthesiology 54:341, 1981.
54.
Tunstall ME: Detecting wakefulness during general
anaesthesia for caesarean section. BMJ 1:1321, 1977.
55.
Tunstall ME: The reduction of amnesic wakefulness
during caesarean section. Anaesthesia 34:316, 1979.
56.
Schultetus RR, Hill CR, Dharmaraj CM, et al: Wakefulness
during cesarean section after anesthetic induction with ketamine, thiopental, or
ketamine and thiopental combined. Anesth Analg 65:723, 1986.
57.
Russell IF: Balanced anesthesia: Does it anesthetize
[letter]? Anesth Analg 64:941, 1985.
58.
Russell IF: Comparison of wakefulness with two
anaesthetic regimens: Total I.V. balanced anaesthesia. Br J Anaesth 58:965, 1986.
59.
Breckenridge J, Aitkenhead AR: Isolated forearm
technique for detection of wakefulness during general anaesthesia [abstract]. Br
J Anaesth 53:665P, 1981.
60.
Bogod DG, Orton JK, Yau HM, et al: Detecting awareness
during general anesthetic caesarean section: An evaluation of two methods. Anaesthesia
45:279, 1990.
61.
Russell IF: Midazolam-alfentanil: An anesthetic?
An investigation using the isolated forearm technique. Br J Anaesth 70:42, 1993.
62.
Abouleish E, Taylor FH: Effect of morphine-diazepam
on signs of anesthesia, awareness, and dreams of patients under NO for cesarean section.
Anesth Analg 55:702, 1976.
63.
Levinson BW: States of awareness during general
anaesthesia: Preliminary communication. Br J Anaesth 37:544, 1965.
64.
Blacher RS: Awareness during surgery [editorial].
Anesthesiology 61:1, 1984.
65.
Bennett HL, Davis HS, Giannini JA: Non-verbal
response to intraoperative conversation. Br J Anaesth 57:174, 1985.
66.
Block RI, Ghoneim MM, Sum Ping ST, et al: Human
learning during general anesthesia and surgery. Br J Anaesth 66:170, 1991.
67.
McLintock TT, Aitken H, Downie CF, et al: Postoperative
analgesic requirements in patients exposed to positive intraoperative suggestions.
BMJ 301:788, 1990.
68.
Woo R, Seltzer JL, Marr A: The lack of response
to suggestion under controlled surgical anesthesia. Acta Anaesthesiol Scand 31:567,
1987.
69.
Eich E, Reeves JL, Katz RL: Anesthesia, amnesia,
and memory/awareness distinction. Anesth Analg 64:1143, 1985.
70.
Block RI, Ghoneim MM, Sum Ping ST, et al: Efficacy
of therapeutic suggestions for improved postoperative recovery presented during general
anesthesia. Anesthesiology 75:746, 1991.
71.
Dwyer R, Bennett HL, Eger EI, et al: Effects of
isoflurane and nitrous oxide in subanesthetic concentrations on memory and responsiveness
in volunteers. Anesthesiology 77:888, 1992.
72.
Veselis RA, Reinsel RA, Feschenko VA, et al: The
comparative amnestic effects of midazolam, propofol, thiopental and fentanyl at equisedative
concentrations. Anesthesiology 87:49, 1997.
73.
Pandit SK, Heisterkamp DV, Cohen PJ: Further studies
on the anti-recall effect of lorazepam: A dose-time-effect relationship. Anesthesiology
45:495, 1976.
74.
Blacher RS: On awakening paralyzed during surgery:
A syndrome of traumatic neurosis. JAMA 234:67, 1975.
75.
Ghoneim MM, Block RI: Learning and memory during
general anesthesia, an update. Anesthesiology 87:387, 1997.
76.
Lennmarken C, Bildfors K, Enlund G, et al: Victims
of awareness. Acta Anaesthesiol Scand 46:229, 2002.
77.
Ghoneim MM: Implicit memory for events during
anesthesia. In Ghoneim MM (ed): Awareness during
Anesthesia. Oxford, Butterworth-Heineman, 2001.
78.
Merkel G, Eger EI II: A comparative study of halothane
and halopropane anesthesia: Including the method for determining equipotency. Anesthesiology
24:346, 1963.
79.
Quasha AL, Eger EI II, Tinker JH: Determination
and applications of MAC. Anesthesiology 53:315, 1980.
80.
Cullen DJ: Drugs and anesthetic depth. In
Smith NT, Miller RD, Corbascio AN (eds): Drug Interactions in Anesthesia. Philadelphia,
Lea & Febiger, 1981, p 287.
81.
Stoelting RK, Longnecker DE, Eger EI II: Minimum
alveolar concentrations in man on awakening from methoxyflurane, halothane, ether
and fluroxene anesthesia: MAC awake. Anesthesiology 33:5, 1970.
82.
Yakaitis RW, Blitt CD, Angiulo JP: End-tidal halothane
concentration for endotracheal intubation. Anesthesiology 47:386, 1977.
83.
Roizen MF, Horrigan RW, Frazer BM: Anesthetic
doses blocking adrenergic (stress) and cardiovascular responses to incision: MAC
BAR. Anesthesiology 54:390, 1981.
84.
Zbinden AM, Maggiorini M, Petersen-Felix S, et
al: Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen
anesthesia. I. Motor reactions. Anesthesiology 80:253, 1994.
85.
Eger EI II, Bahlman SH: Is the end-tidal anesthetic
partial pressure an accurate measure of the arterial anesthetic partial pressure?
Anesthesiology 35:301, 1971.
86.
Saidman LJ, Eger EI II: Effect of nitrous oxide
and of narcotic premedication on the alveolar concentration of halothane required
for anesthesia. Anesthesiology 25:302, 1964.
87.
de Jong RH, Eger EI II: MAC expanded: AD50
and AD95
values of common inhalation anesthetics in man. Anesthesiology
42:384, 1975.
88.
Waud DR: On biological assays involving quantal
responses. J Pharmacol Exp Ther 183:577, 1972.
89.
Torri G, Damia G, Fabiani ML: Effect of nitrous
oxide on the anaesthetic requirement of enflurane. Br J Anaesth 46:468, 1974.
90.
Eger EI, Koblin D, Harris RA, et al. Hypothesis:
Inhaled anesthetics produce immobility and amnesia by different mechanisms at different
sites. Anesth Analg 84:915, 1997.
91.
Cullen DJ, Eger EI II, Stevens WC, et al: Clinical
signs of anesthesia. Anesthesiology 36:21, 1972.
92.
Zbinden AM, Petersen-Felix S, Thomson DA: Anesthetic
depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia.
II. Hemodynamic responses. Anesthesiology 80:261, 1994.
93.
King BD, Harris LC Jr, Greifenstein FE, et al:
Reflex circulatory responses to direct laryngoscopy and tracheal intubation performed
during general anesthesia. Anesthesiology 12:556, 1951.
94.
Stoelting RK: Circulatory changes during direct
laryngoscopy and tracheal intubation: Influence of duration of laryngoscopy with
or without prior lidocaine. Anesthesiology 47:381, 1977.
95.
Brett CM, Fisher DM: Thiopental dose-response
relations in unpremedicated infants, children, and adults. Anesth Analg 66:1024,
1987.
96.
Avram MJ, Sanghvi R, Henthorn TK, et al: Determinants
of thiopental induction dose requirements. Anesth Analg 76:10, 1993.
97.
Jacobs RJ, Reves JG: Effect site equilibration
time is a determinant of induction dose requirement. Anesth Analg 76:1, 1993.
98.
Becker KE Jr: Plasma levels of thiopental necessary
for anesthesia. Anesthesiology 49:192, 1978.
99.
Hung OR, Varvel JR, Shafer SL, et al: Thiopental
pharmacodynamics. II. Quantitation of clinical and electroencephalographic depth
of anesthesia. Anesthesiology 77:237, 1992.
100.
Vuyk J, Lim T, Engbers FHM, et al: Pharmacodynamics
of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery
in female patients. Anesthesiology 78:1036, 1993.
101.
Stanski DR, Shafer SL: Quantifying anesthetic
drug interaction: Implications for drug dosing. Anesthesiology 83:1, 1995.
102.
Tammisto T, Aromaa U, Korttila K: The role of
thiopental and fentanyl in the production of balanced anaesthesia. Acta Anaesthesiol
Scand 24:31, 1980.
103.
Neff W, Mayer EC, de la Luz Percales M: Nitrous
oxide and oxygen anesthesia with curare relaxation. Calif Med 66:67, 1947.
104.
Lowenstein E, Hallowell P, Levine FH, et al:
Cardiovascular response to large doses of intravenous morphine in man. N Engl J
Med 281:1389, 1969.
105.
Stanley TH, Webster LR: Anesthetic requirements
and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia
in man. Anesth Analg 57:411, 1978.
106.
Waller JL, Hug CC Jr, Nagle DM, et al: Hemodynamic
changes during fentanyl-oxygen anesthesia for aortocoronary bypass operation. Anesthesiology
55:212, 1981.
107.
Hynynen M, Takkunen O, Salmenpera M, et al: Continuous
infusion of fentanyl or alfentanil for coronary artery surgery: Plasma opiate concentrations,
haemodynamics and postoperative course. Br J Anaesth 58:1252, 1986.
108.
Philbin DM, Rosow CE, Schneider RC, et al: Fentanyl
and sufentanil anesthesia revisited: How much is enough? Anesthesiology 73:5, 1990.
109.
Thompson IR, Henderson BT, Singh K, et al: Concentration-response
relationships for fentanyl and sufentanil in patients undergoing coronary artery
bypass grafting. Anesthesiology 89:852, 1998.
110.
Murphy MR, Hug CC Jr: The anesthetic potency
of fentanyl in terms of its reduction of enflurane MAC. Anesthesiology 57:485, 1982.
111.
Hall RI, Murphy MR, Hug CC Jr: The enflurane
sparing effect of sufentanil in dogs. Anesthesiology 67:518, 1987.
112.
Hall RI, Szlam F, Hug CC Jr: The enflurane-sparing
effect of alfentanil in dogs. Anesth Analg 66:1287, 1987.
113.
Murphy MR, Hug CC Jr: The enflurane sparing effect
of morphine, butorphanol, and nalbuphine. Anesthesiology 57:489, 1982.
114.
Glass PSA: Anesthetic drug interactions: An
insight into general anesthesia—its mechanisms and dosing strategies. Anesthesiology
88:5, 1998.
115.
Glass PSA, Gan TJ, Howell S, et al: Drug interactions:
Volatile anesthetics and opiates. J Clin Anesth 9:18S, 1997.
116.
Katoh T, Kobayashi S, Suzuke A, et al: The effect
of fentanyl on sevoflurane requirements for somatic and sympathetic responses to
surgical incision. Anesthesiology 90:398, 1999.
117.
Katoh T, Ikeda K: The effect of fentanyl on sevoflurane
requirements for loss of consciousness and skin incision. Anesthesiology 88:18,
1998.
118.
Ausems ME, Vuyk J, Hug CC Jr, et al: Comparison
of computer-assisted infusion versus intermittent bolus administration of alfentanil
as a supplement to nitrous oxide for lower abdominal surgery. Anesthesiology 68:851,
1988.
119.
Lemmens HJM, Bovill JG, Hennis PJ, et al: Alcohol
consumption alters the pharmacodynamics of alfentanil. Anesthesiology 71:669, 1989.
120.
Lemmens HJM, Burm AGL, Bovill JG, et al: Pharmacodynamics
of alfentanil: The role of protein binding. Anesthesiology 76:65, 1992.
121.
Egan TD, Minto CF, Hermann DJ, et al: Remifentanil
vs alfentanil, comparative pharmacokinetics and pharmacodynamics in healthy adult
male volunteers. Anesthesiology 84:821, 1996.
122.
Minto CF, Schnider TW, Egan TD, et al: Influence
of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil.
I. Model development. Anesthesiology 86:10, 1997.
123.
Minto CF, Schnider TW, Shafer SL: Pharmacokinetics
and pharmacodynamics of remifentanil. II. Model development. Anesthesiology 86:24,
1997.
124.
Drover DR, Lemmens HJM: Population pharmacodynamics
and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia
for elective abdominal surgery. Anesthesiology 89:869, 1998.
125.
Scott JC, Ponganis KV, Stanski DR: EEG quantitation
of narcotic effect: The comparative pharmacodynamics of fentanyl and alfentanil.
Anesthesiology 62:234, 1985.
126.
Glass PS, Doherty M, Jacobs JR, et al: Plasma
concentration of fentanyl, with 70% nitrous oxide, to prevent movement at skin incision.
Anesthesiology 78:842, 1993.
127.
Brazier MAB: The effect of drugs on the electroencephalogram
of man. Clin Pharmacol Ther 5:102, 1964.
128.
Caton R: The electrical currents of the brain
[abstract]. BMJ 2:278, 1875.
129.
Berger H: Uber das Elektrenkaphalogramm des Menschen.
Arch Psychiatry 101:452, 1933.
130.
Gibbs FA, Gibbs EL, Lennox WG: Effect on the
electro-encephalogram of certain drugs which influence nervous activity. Arch Intern
Med 60:154, 1937.
131.
Faulconer A Jr: Correlation of concentrations
of ether in arterial blood with electro-encephalographic patterns occurring during
ether-oxygen and during nitrous oxide, oxygen and ether anesthesia of human surgical
patients. Anesthesiology 13:361, 1952.
132.
Kuramoto T, Oshita S, Takeshita H, et al: Modification
of the relationship between cerebral metabolism, blood flow, and electroencephalogram
by stimulation during anesthesia in the dog. Anesthesiology 51:211, 1979.
133.
Levy WJ, Shapiro HM, Maruchak G, et al: Automated
EEG processing for intraoperative monitoring: A comparison of techniques. Anesthesiology
53:223, 1980.
134.
Gregory TK, Pettus DC: An electroencephalographic
processing algorithm specifically intended for analysis of cerebral electrical activity.
J Clin Monit 2:190, 1986.
135.
Rampil IJ: What every neuroanesthesiologist should
know about electroencephalograms and computerized monitors. Anesthesiol Clin North
Am 10:683, 1992.
136.
Prior PF: The EEG and detection of responsiveness
during anaesthesia and coma. In Rosen M, Lunn JN
(eds): Consciousness, Awareness, and Pain in General Anesthesia. London, Butterworths,
1987, p 34.
137.
Bimar J, Bellville JW: Arousal reactions during
anesthesia in man. Anesthesiology 47:449, 1977.
138.
Miyauchi Y, Sakabe T, Maekawa T, et al: Responses
of EEG, cerebral oxygen consumption and blood flow to peripheral nerve stimulation
during thiopentone anaesthesia in the dog. Can Anaesth Soc J 32:491, 1985.
139.
Clark DL, Rosner BS: Neurophysiologic effects
of general anesthetics. I. The electroencephalogram and sensory evoked responses
in man. Anesthesiology 38:564, 1973.
140.
Galla SJ, Rocco AG, Vandam LD: Evaluation of
the traditional signs and stages of anesthesia: An electroencephalographic and clinical
study. Anesthesiology 19:328, 1958.
141.
Levy WJ: Intraoperative EEG patterns: Implications
for EEG monitoring. Anesthesiology 60:430, 1984.
142.
Berezowskyj JL, McEwen JA, Anderson GB, et al:
A study of anaesthesia depth by power spectral analysis of the electroencephalogram
(EEG). Can Anaesth Soc J 23:1, 1976.
143.
Drummond JC, Brann CA, Perkins DE, et al: A comparison
of median frequency, spectral edge frequency, a frequency band power ratio, total
power and dominance shift in the determination of depth of anesthesia. Acta Anaesthesiol
Scand 35:693, 1991.
144.
Long CW, Shah NK, Lounghlin C, et al: A comparison
of EEG determinants of near awakening from isoflurane and fentanyl anesthesia. Anesth
Analg 69:169, 1989.
145.
Dwyer RC, Rampil IJ, Eger EI, et al: The electroencephalogram
does not predict depth of isoflurane anesthesia. Anesthesiology 81:403, 1994.
146.
Stanski DR: Pharmacodynamic modeling of anesthetic
EEG drug effects. Annu Rev Pharmacol Toxicol 32:421, 1992.
147.
Gregg K, Varvel JR, Shafer SL: Application of
semilinear canonical correlation to the measurement of opioid drug effect. J Pharmacokinet
Biopharm 20:611, 1992.
148.
Schnider TW, Minto CF, Fiset P, et al: Semilinear
canonical correlation applied to the measurement of the electroencephalographic effects
of midazolam and flumazenil reversal. Anesthesiology 84:510, 1996.
149.
Schnider, TW, Minto CF, Shafer SL, et al: The
influence of age on propofol pharmacodynamics. Anesthesiology 90:1502, 1999.
150.
Gambús PL, Gregg KM, Shafer SL: Validation
of the alfentanil canonical univariate parameter as a measure of opioid effect on
the electroencephalogram. Anesthesiology 83:747–756, 1995.
